Medical Components, Inc.

Medical Components, Inc. specializes in vascular catheter-related products. Their portfolio includes nonimplantable vascular catheter introduction sets, securement devices (like the StatLock PICC Plus), repair kits for catheters and infusion lines (such as Split Stream and Tesio repair solutions), and valved peelable introducers. These devices are primarily designed for midline and peripheral intravenous access, including power-injectable sets for CT imaging.

Medical Components, Inc. is headquartered in Harleysville, Pennsylvania, USA. As a US-based manufacturer, its devices are regulated under the FDA’s classification system (Class I, II, IIa, IIb, and Unclassified). Some of its products are also listed in the EU’s eudamed registry, indicating compliance with European medical device regulations, though this does not imply approval—only that the devices are registered where applicable.

Medical Components, Inc.’s devices appear in the FDA’s 510(k) clearance database and the EU’s eudamed registry. The FDA’s 510(k) pathway applies to Class II and some Class IIb devices, demonstrating that these products have been cleared for marketing in the US through a premarket submission process. The inclusion in eudamed reflects compliance with EU medical device regulations, where the company’s products may be registered for distribution within the European Economic Area.

Medical Components, Inc.’s devices span multiple FDA classification tiers: Class I (generally low-risk, often exempt from premarket submission), Class II (requires special controls like performance standards or postmarket surveillance), Class IIa and IIb (higher-risk variants within Class II), and Unclassified (U) devices, which may require case-by-case evaluation. The classification determines regulatory requirements, such as labeling, postmarket reporting, or premarket notifications like 510(k)s.

No, Medical Components, Inc. does not manufacture implantable devices. Its products are exclusively nonimplantable, such as catheter introduction sets, securement devices, and repair kits. This distinction matters because nonimplantable devices typically face lower regulatory scrutiny than implantables (e.g., no long-term biocompatibility testing requirements), though they still must meet safety and performance standards for their intended use, like sterility or infection control.